Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,663 public trials 1,507 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT06161025

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Sylvester Comprehensive Cancer Center at Lennar Coral Gables, Florida, United States
  • Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
View all 164 locations
View Trial Details
Recruiting

AOH1996 for the Treatment of Refractory Solid Tumors

NCT05227326

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +39 more
Locations
  • Honor Health Research and Innovation Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
View Trial Details
Recruiting

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

NCT07022483

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Broward Health Medical Center Fort Lauderdale, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
View all 75 locations
View Trial Details
Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
Locations
  • Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

NCT05460000

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
Locations
  • Universitätsklinik Innsbruck Innsbruck, Austria
  • Cliniques Universitaires St. Luc Brussels, Belgium
  • UZ Gent Ghent, Belgium
  • Jessa ziekenhuis Hasselt, Belgium
View all 50 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

NCT06824467

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Alabama at Birmingham ( Site 0006) Birmingham, Alabama, United States
  • Alaska Women's Cancer Care ( Site 0096) Anchorage, Alaska, United States
  • UCSF Medical Center at Mission Bay ( Site 0013) San Francisco, California, United States
  • John Muir Health Cancer Center ( Site 0016) Walnut Creek, California, United States
View all 186 locations
View Trial Details
Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

NCT06952504

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 6033) Mobile, Alabama, United States
  • Alaska Women's Cancer Care ( Site 6036) Anchorage, Alaska, United States
  • CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014) Irvine, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020) Orange, California, United States
View all 261 locations
View Trial Details

Related conditions